Finding the correct arsenal for preventing plaques, tangle formation and neuroinflammation is the holy grail for scientists studying Alzheimer’s disease. All three join together to disrupt communication between neurons—leading to an eventual complete loss of autonomy. The Newfound Focus on Tau Plaques are composed of amyloid protein and have been the major ...
November 9, 2017
A Letter from Cure Alzheimer’s Fund President & CEO, Tim Armour: For 5 years now, we’ve been saying the same thing – with increased federal funding, we will find a cure for Alzheimer’s. We have urged the federal government to make a national commitment to increase research funding and in the Senate’s ...
February 10, 2010
2019 Alzheimer’s disease is a devastating neurodegenerative disorder affecting 1 in 3 dying seniors and costing $236 billion annually in the United States alone. Its prevalence is increasing rapidly in an aging population, and there currently is no cure. Recent genetic studies provide new hope for therapeutic avenues, but translating genetic ...
January 5, 2017
In Response to Nicholas Wade’s NYT column, June 12, 2010: “A Decade Later, Genetic Map Yields Few New Clues”But real progress IS being made. The promised breakthroughs and cures from the Human Genome Project may have been too optimistic from a timing perspective. But Wade may be too pessimistic when he ...
June 18, 2010
On December 3rd, Cure Alzheimer’s Fund’s Rudy Tanzi took part in a panel discussion on breakthrough science at the Partnering for Cures meeting. Partnering for Cures brought together philanthropy, medical research foundations, and the biotechnology and pharmaceutical industries in an effort to create collaborations for the development of new medical solutions. The ...
December 15, 2009
Nikki Zazzelli created Revive Jewelry to establish a community of change makers, people who want to use their buying power for good, support critical research, spread awareness, and find cures. The 24 pieces in the Alzheimer’s Collection are handmade and inspired by cell images of Alzheimer’s disease. Handmade in the ...
October 30, 2020
The path from research discovery to drug development can be a long one. Current estimates target the time for an Alzheimer’s drug to get to market at around 12 years. However, with new technological advances in such areas as genetics, we are optimistic that scientific opportunities have never been greater to ...
August 20, 2009
On June 16, 2014, the Finance Department employees of Erickson Living—a Baltimore, Maryland-based company that develops and manages senior living communities—held a “memory walk” to raise money for Cure Alzheimer’s Fund. “We wanted to donate to a charity that was relevant to our residents,” said Colleen Stafford, senior financial analyst, who ...
September 22, 2014
Rik Ossenkoppele is an associate professor in Translational Neuroscience and PI at the Alzheimercenter Amsterdam of the Amsterdam UMC and at Lund University in Sweden. He works on the intersection between neuroimaging, biomarkers and cognition in Alzheimer’s disease. His main motivation is to contribute to improving the diagnostic/prognostic work-up (short-term ...
May 11, 2022
Join us on November 13th for an evening of education with best selling author and neuroscientist Lisa Genova. You won’t want to miss this unique opportunity as Lisa shares insight into the latest science, discoveries, research and reality of living with Alzheimer’s disease. A new Alzheimer’s case develops every 65 seconds ...
October 10, 2019
